Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 44 | 2024 | 6746 | 3.100 |
Why?
|
Aspirin | 13 | 2024 | 3286 | 1.790 |
Why?
|
Escherichia coli Proteins | 7 | 2024 | 1047 | 1.770 |
Why?
|
Aberrant Crypt Foci | 3 | 2017 | 11 | 1.540 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2024 | 2244 | 1.360 |
Why?
|
Membrane Proteins | 10 | 2018 | 7785 | 1.270 |
Why?
|
Saccharomyces cerevisiae | 8 | 2018 | 2686 | 1.130 |
Why?
|
Anticarcinogenic Agents | 3 | 2018 | 249 | 1.120 |
Why?
|
Fibroblast Growth Factors | 3 | 2020 | 859 | 1.080 |
Why?
|
Escherichia coli | 5 | 2024 | 4163 | 0.990 |
Why?
|
Renal Dialysis | 3 | 2024 | 1691 | 0.950 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 589 | 0.880 |
Why?
|
Adenoma | 6 | 2021 | 2138 | 0.870 |
Why?
|
Feces | 7 | 2024 | 1429 | 0.860 |
Why?
|
Body Composition | 3 | 2020 | 2381 | 0.830 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 382 | 0.780 |
Why?
|
Chemoprevention | 3 | 2020 | 325 | 0.780 |
Why?
|
Prokaryotic Cells | 2 | 2018 | 49 | 0.750 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 605 | 0.730 |
Why?
|
Crystallography, X-Ray | 4 | 2013 | 1970 | 0.710 |
Why?
|
Potassium | 1 | 2024 | 1313 | 0.700 |
Why?
|
Liposomes | 1 | 2023 | 778 | 0.680 |
Why?
|
Green Fluorescent Proteins | 5 | 2012 | 2046 | 0.670 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1362 | 0.610 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2018 | 54 | 0.600 |
Why?
|
Health | 1 | 2020 | 393 | 0.600 |
Why?
|
Dinoprostone | 1 | 2020 | 596 | 0.590 |
Why?
|
Eukaryotic Cells | 1 | 2018 | 195 | 0.580 |
Why?
|
Carcinoma | 3 | 2017 | 2344 | 0.570 |
Why?
|
Detergents | 3 | 2013 | 233 | 0.550 |
Why?
|
Crystallization | 3 | 2014 | 521 | 0.510 |
Why?
|
Thermus thermophilus | 2 | 2017 | 22 | 0.490 |
Why?
|
Industrial Microbiology | 1 | 2014 | 7 | 0.490 |
Why?
|
Colonic Polyps | 2 | 2019 | 540 | 0.480 |
Why?
|
Genome-Wide Association Study | 8 | 2024 | 12202 | 0.470 |
Why?
|
Smoking | 5 | 2023 | 8975 | 0.470 |
Why?
|
Data Collection | 2 | 2020 | 3287 | 0.460 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2190 | 0.460 |
Why?
|
International Cooperation | 1 | 2020 | 1416 | 0.450 |
Why?
|
Aging | 4 | 2020 | 8486 | 0.440 |
Why?
|
Microsatellite Instability | 6 | 2024 | 697 | 0.440 |
Why?
|
Hypertension | 3 | 2023 | 8358 | 0.420 |
Why?
|
Colonoscopy | 3 | 2017 | 1355 | 0.420 |
Why?
|
Protein Stability | 5 | 2018 | 563 | 0.420 |
Why?
|
Molecular Dynamics Simulation | 4 | 2024 | 405 | 0.420 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3055 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2024 | 15366 | 0.410 |
Why?
|
Postprandial Period | 4 | 2021 | 304 | 0.410 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3167 | 0.410 |
Why?
|
Chromatography, Gel | 4 | 2018 | 640 | 0.410 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2500 | 0.400 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2011 | 25 | 0.400 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1841 | 0.400 |
Why?
|
Gene Expression | 4 | 2020 | 7580 | 0.400 |
Why?
|
Symporters | 2 | 2011 | 360 | 0.390 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 403 | 0.390 |
Why?
|
Metagenome | 5 | 2023 | 421 | 0.390 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.390 |
Why?
|
Dietary Fiber | 4 | 2024 | 754 | 0.380 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 477 | 0.380 |
Why?
|
Neisseria meningitidis | 1 | 2011 | 112 | 0.380 |
Why?
|
Patient Discharge | 1 | 2024 | 3311 | 0.380 |
Why?
|
Proteomics | 4 | 2024 | 3709 | 0.380 |
Why?
|
Recombinant Fusion Proteins | 4 | 2012 | 3722 | 0.360 |
Why?
|
Aged | 46 | 2024 | 164236 | 0.350 |
Why?
|
Hyperplasia | 1 | 2013 | 1153 | 0.340 |
Why?
|
Humans | 106 | 2024 | 746044 | 0.340 |
Why?
|
Risk Factors | 34 | 2024 | 72416 | 0.340 |
Why?
|
Immunoassay | 1 | 2013 | 731 | 0.340 |
Why?
|
Prospective Studies | 31 | 2024 | 53218 | 0.330 |
Why?
|
Plasmids | 2 | 2012 | 2275 | 0.330 |
Why?
|
Deoxycholic Acid | 1 | 2008 | 53 | 0.320 |
Why?
|
Diet | 10 | 2024 | 7881 | 0.320 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2448 | 0.320 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1727 | 0.320 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2008 | 101 | 0.320 |
Why?
|
Protein Conformation | 3 | 2014 | 3959 | 0.320 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2024 | 2029 | 0.310 |
Why?
|
Fusobacterium nucleatum | 2 | 2021 | 164 | 0.310 |
Why?
|
Sodium | 3 | 2022 | 1604 | 0.300 |
Why?
|
Cell Membrane | 1 | 2017 | 3687 | 0.300 |
Why?
|
Colon | 3 | 2021 | 1769 | 0.300 |
Why?
|
Glucose Transporter Type 1 | 2 | 2023 | 189 | 0.300 |
Why?
|
Incidence | 9 | 2024 | 20812 | 0.300 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2019 | 1061 | 0.300 |
Why?
|
Self Report | 8 | 2022 | 3589 | 0.300 |
Why?
|
Models, Molecular | 3 | 2013 | 5379 | 0.290 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 451 | 0.290 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2023 | 377 | 0.290 |
Why?
|
Male | 60 | 2024 | 351093 | 0.290 |
Why?
|
Middle Aged | 48 | 2024 | 214412 | 0.290 |
Why?
|
Female | 60 | 2024 | 382109 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 8 | 2024 | 17434 | 0.280 |
Why?
|
Vaccination | 4 | 2022 | 3282 | 0.270 |
Why?
|
Biotechnology | 1 | 2008 | 279 | 0.260 |
Why?
|
Blood Pressure | 2 | 2023 | 8404 | 0.260 |
Why?
|
CpG Islands | 5 | 2024 | 1200 | 0.250 |
Why?
|
Potassium-Hydrogen Antiporters | 1 | 2024 | 2 | 0.240 |
Why?
|
Membrane Transport Proteins | 3 | 2024 | 1031 | 0.240 |
Why?
|
Genetic Vectors | 2 | 2012 | 3346 | 0.240 |
Why?
|
Protons | 3 | 2022 | 1116 | 0.240 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6508 | 0.240 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2024 | 44 | 0.240 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1215 | 0.240 |
Why?
|
Probenecid | 1 | 2024 | 73 | 0.230 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2022 | 2503 | 0.230 |
Why?
|
Glucose Transporter Type 3 | 1 | 2023 | 16 | 0.230 |
Why?
|
Cognition | 6 | 2024 | 6773 | 0.230 |
Why?
|
Antiporters | 2 | 2022 | 276 | 0.220 |
Why?
|
Blood Glucose | 4 | 2021 | 6213 | 0.220 |
Why?
|
Microdissection | 2 | 2014 | 151 | 0.220 |
Why?
|
Case-Control Studies | 8 | 2024 | 21673 | 0.220 |
Why?
|
Feeding Behavior | 4 | 2021 | 3156 | 0.220 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2023 | 177 | 0.210 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 942 | 0.200 |
Why?
|
Histidine | 1 | 2022 | 307 | 0.200 |
Why?
|
Ions | 1 | 2022 | 261 | 0.200 |
Why?
|
Salicylic Acid | 1 | 2021 | 62 | 0.200 |
Why?
|
Ageusia | 1 | 2021 | 18 | 0.200 |
Why?
|
Glutathione | 1 | 2024 | 565 | 0.200 |
Why?
|
DNA Glycosylases | 1 | 2022 | 123 | 0.190 |
Why?
|
Proportional Hazards Models | 7 | 2022 | 12273 | 0.190 |
Why?
|
Pandemics | 8 | 2022 | 8434 | 0.190 |
Why?
|
Mass Spectrometry | 3 | 2024 | 2171 | 0.190 |
Why?
|
Biological Assay | 1 | 2024 | 629 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2023 | 38752 | 0.190 |
Why?
|
Mutation | 9 | 2024 | 29614 | 0.180 |
Why?
|
Disease Progression | 6 | 2023 | 13303 | 0.180 |
Why?
|
Kidney Tubules | 1 | 2022 | 468 | 0.180 |
Why?
|
Progestins | 1 | 2022 | 299 | 0.180 |
Why?
|
Cough | 2 | 2021 | 584 | 0.180 |
Why?
|
Genetic Loci | 3 | 2024 | 2554 | 0.180 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 6931 | 0.180 |
Why?
|
Adult | 36 | 2024 | 214958 | 0.170 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.170 |
Why?
|
DNA Methylation | 6 | 2024 | 4258 | 0.170 |
Why?
|
Precancerous Conditions | 2 | 2019 | 972 | 0.170 |
Why?
|
Genes, Reporter | 2 | 2018 | 1531 | 0.170 |
Why?
|
Bacterial Proteins | 2 | 2017 | 3784 | 0.170 |
Why?
|
Risk Assessment | 8 | 2024 | 23453 | 0.170 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5764 | 0.170 |
Why?
|
Dyspnea | 3 | 2021 | 1308 | 0.160 |
Why?
|
Appetite | 1 | 2021 | 248 | 0.160 |
Why?
|
Masks | 1 | 2021 | 200 | 0.160 |
Why?
|
Time Factors | 9 | 2021 | 39587 | 0.160 |
Why?
|
Fruit | 1 | 2024 | 1150 | 0.160 |
Why?
|
Vegetables | 1 | 2024 | 1188 | 0.160 |
Why?
|
Glucosinolates | 1 | 2018 | 10 | 0.160 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4091 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 790 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2018 | 48 | 0.150 |
Why?
|
Systole | 2 | 2020 | 928 | 0.150 |
Why?
|
Diastole | 2 | 2020 | 775 | 0.150 |
Why?
|
Young Adult | 15 | 2022 | 57106 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1126 | 0.150 |
Why?
|
United States | 15 | 2022 | 70383 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.150 |
Why?
|
Prognosis | 8 | 2021 | 29068 | 0.150 |
Why?
|
Aged, 80 and over | 13 | 2022 | 57557 | 0.140 |
Why?
|
Biological Availability | 1 | 2018 | 394 | 0.140 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 666 | 0.140 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14113 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2023 | 12208 | 0.140 |
Why?
|
Fever | 2 | 2021 | 1604 | 0.140 |
Why?
|
Folic Acid | 1 | 2023 | 1284 | 0.140 |
Why?
|
Calcitriol | 1 | 2018 | 294 | 0.140 |
Why?
|
Apathy | 1 | 2017 | 106 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4515 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1814 | 0.140 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2017 | 107 | 0.140 |
Why?
|
Cohort Studies | 10 | 2024 | 40503 | 0.140 |
Why?
|
Lipid Bilayers | 1 | 2018 | 380 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 82 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2000 | 488 | 0.140 |
Why?
|
Obesity | 4 | 2023 | 12670 | 0.140 |
Why?
|
Water | 1 | 2022 | 1395 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 176 | 0.130 |
Why?
|
Metagenomics | 4 | 2021 | 432 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
Prostaglandins | 1 | 2017 | 402 | 0.130 |
Why?
|
Prevalence | 3 | 2021 | 15308 | 0.130 |
Why?
|
Protein Unfolding | 2 | 2017 | 56 | 0.130 |
Why?
|
Kinetics | 1 | 2023 | 6352 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25177 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1338 | 0.130 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3784 | 0.130 |
Why?
|
Organoids | 1 | 2021 | 711 | 0.130 |
Why?
|
Mass Screening | 3 | 2020 | 5329 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15537 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2021 | 823 | 0.120 |
Why?
|
Protein Binding | 3 | 2018 | 9278 | 0.120 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 3077 | 0.120 |
Why?
|
Chemical Fractionation | 1 | 2014 | 63 | 0.120 |
Why?
|
Bacteria | 3 | 2021 | 2133 | 0.120 |
Why?
|
Binding Sites | 4 | 2024 | 6025 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 363 | 0.120 |
Why?
|
Health Personnel | 4 | 2021 | 3215 | 0.120 |
Why?
|
Sex Factors | 4 | 2021 | 10279 | 0.120 |
Why?
|
Cell Fractionation | 1 | 2014 | 252 | 0.120 |
Why?
|
Glucose | 2 | 2023 | 4302 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 1690 | 0.120 |
Why?
|
Energy Intake | 1 | 2021 | 2114 | 0.110 |
Why?
|
Ambulatory Care | 1 | 2024 | 2717 | 0.110 |
Why?
|
Static Electricity | 1 | 2013 | 264 | 0.110 |
Why?
|
Adolescent | 11 | 2021 | 86202 | 0.110 |
Why?
|
Models, Chemical | 1 | 2014 | 614 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2020 | 875 | 0.100 |
Why?
|
Intestinal Mucosa | 2 | 2014 | 2987 | 0.100 |
Why?
|
Triglycerides | 1 | 2020 | 2432 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1356 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1570 | 0.100 |
Why?
|
Educational Status | 1 | 2020 | 2483 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1853 | 0.100 |
Why?
|
Galactokinase | 1 | 2012 | 17 | 0.100 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4175 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3496 | 0.100 |
Why?
|
Eukaryota | 1 | 2013 | 99 | 0.100 |
Why?
|
Stilbenes | 1 | 2012 | 154 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4313 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6298 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3694 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15009 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5760 | 0.100 |
Why?
|
Age Factors | 4 | 2021 | 18146 | 0.100 |
Why?
|
Shewanella | 1 | 2010 | 11 | 0.090 |
Why?
|
Aspartic Acid | 1 | 2013 | 575 | 0.090 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2012 | 197 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2017 | 1428 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2586 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6831 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2042 | 0.090 |
Why?
|
Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 53 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9443 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1094 | 0.090 |
Why?
|
Genes, ras | 1 | 2013 | 654 | 0.090 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2012 | 1847 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3615 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3124 | 0.090 |
Why?
|
Phenotype | 4 | 2024 | 16245 | 0.090 |
Why?
|
Bile Acids and Salts | 1 | 2011 | 368 | 0.080 |
Why?
|
Exercise | 2 | 2023 | 5686 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4590 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12018 | 0.080 |
Why?
|
Protein Folding | 1 | 2013 | 845 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2545 | 0.080 |
Why?
|
Biological Transport | 2 | 2024 | 2077 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6095 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2023 | 2142 | 0.080 |
Why?
|
Health Status | 2 | 2020 | 4016 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2451 | 0.080 |
Why?
|
Terminal Care | 1 | 2000 | 1725 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2013 | 965 | 0.080 |
Why?
|
Constipation | 2 | 2023 | 549 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1059 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3607 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3548 | 0.080 |
Why?
|
Phosphorylation | 2 | 2024 | 8294 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4248 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2372 | 0.070 |
Why?
|
Animals | 8 | 2024 | 166331 | 0.070 |
Why?
|
Nanotechnology | 1 | 2013 | 698 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8511 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4356 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4401 | 0.070 |
Why?
|
Sleep | 1 | 2022 | 4646 | 0.070 |
Why?
|
Mutant Proteins | 1 | 2008 | 491 | 0.070 |
Why?
|
Risk | 2 | 2016 | 9520 | 0.070 |
Why?
|
Parents | 1 | 2000 | 3462 | 0.070 |
Why?
|
Decision Making | 1 | 2000 | 3855 | 0.070 |
Why?
|
Diet Surveys | 2 | 2021 | 1150 | 0.070 |
Why?
|
Genomics | 1 | 2022 | 5694 | 0.070 |
Why?
|
Diarrhea | 2 | 2023 | 1327 | 0.070 |
Why?
|
Software | 1 | 2020 | 4399 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10351 | 0.060 |
Why?
|
Lipids | 1 | 2017 | 3290 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6470 | 0.060 |
Why?
|
Menopause | 2 | 2024 | 1615 | 0.060 |
Why?
|
Independent Living | 2 | 2020 | 558 | 0.060 |
Why?
|
Temperature | 1 | 2012 | 2194 | 0.060 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 453 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 10592 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1951 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9310 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2069 | 0.060 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2007 | 498 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Depression | 2 | 2021 | 7826 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9209 | 0.060 |
Why?
|
Genotype | 3 | 2024 | 12773 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2552 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3609 | 0.050 |
Why?
|
Archaea | 1 | 2023 | 59 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2389 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7219 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 2022 | 188 | 0.050 |
Why?
|
Trophoblasts | 1 | 2023 | 214 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5688 | 0.050 |
Why?
|
Neoplasms | 2 | 2020 | 21688 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1972 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 458 | 0.050 |
Why?
|
Rats | 2 | 2024 | 23680 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 626 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 82 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6056 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 78 | 0.050 |
Why?
|
Meat | 1 | 2024 | 576 | 0.050 |
Why?
|
Food Microbiology | 1 | 2021 | 76 | 0.050 |
Why?
|
Blastocystis | 1 | 2021 | 19 | 0.050 |
Why?
|
Southeastern United States | 1 | 2000 | 87 | 0.050 |
Why?
|
Hong Kong | 1 | 2000 | 154 | 0.050 |
Why?
|
Body Mass Index | 3 | 2023 | 12633 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11036 | 0.040 |
Why?
|
Taste Disorders | 1 | 2020 | 36 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8355 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 51 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 848 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 166 | 0.040 |
Why?
|
England | 1 | 2020 | 515 | 0.040 |
Why?
|
Sulfur | 1 | 2020 | 166 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2023 | 603 | 0.040 |
Why?
|
Hunger | 1 | 2021 | 202 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 265 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8304 | 0.040 |
Why?
|
Glycemic Index | 1 | 2021 | 391 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 86 | 0.040 |
Why?
|
Israel | 1 | 2021 | 707 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 150 | 0.040 |
Why?
|
Life Support Care | 1 | 2000 | 222 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7222 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 471 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 298 | 0.040 |
Why?
|
C-Peptide | 1 | 2020 | 424 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2024 | 742 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2000 | 264 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2800 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2023 | 1131 | 0.040 |
Why?
|
Mental Health | 2 | 2022 | 3091 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 220 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2624 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 1207 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13538 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1152 | 0.040 |
Why?
|
Cross-Cultural Comparison | 1 | 2000 | 622 | 0.040 |
Why?
|
Levodopa | 1 | 2017 | 216 | 0.040 |
Why?
|
Australia | 1 | 2000 | 1214 | 0.040 |
Why?
|
Odds Ratio | 2 | 2021 | 9596 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1980 | 0.030 |
Why?
|
Safety | 1 | 2021 | 1146 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1174 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 992 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1647 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11940 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 1997 | 292 | 0.030 |
Why?
|
Eating | 1 | 2022 | 1531 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 841 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2918 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 556 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1520 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2764 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1335 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2020 | 886 | 0.030 |
Why?
|
Crack Cocaine | 1 | 1995 | 32 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2017 | 349 | 0.030 |
Why?
|
Dietary Proteins | 1 | 2020 | 939 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 63661 | 0.030 |
Why?
|
Postmenopause | 1 | 2024 | 2461 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 668 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1082 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1575 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1186 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1760 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2387 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 775 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1093 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 11089 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1682 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14537 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1300 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2385 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1611 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4119 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 1980 | 0.030 |
Why?
|
Dimerization | 1 | 2014 | 886 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1731 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1519 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 280 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1294 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2272 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 1980 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 1997 | 1152 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 866 | 0.020 |
Why?
|
Polysomnography | 1 | 2017 | 1788 | 0.020 |
Why?
|
Crystallography | 1 | 2010 | 111 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 495 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2736 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3324 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 874 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2000 | 5092 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1800 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2887 | 0.020 |
Why?
|
Cocaine | 1 | 1995 | 982 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3751 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3960 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1695 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1997 | 1395 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1875 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3239 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7673 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 78297 | 0.020 |
Why?
|
Nurses | 1 | 2017 | 2441 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8593 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2852 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10094 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9116 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1341 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11384 | 0.020 |
Why?
|
Emotions | 1 | 2017 | 2672 | 0.020 |
Why?
|
Mice | 2 | 2024 | 80087 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6732 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9170 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 17834 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5048 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6137 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6453 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2017 | 2815 | 0.010 |
Why?
|
Kidney | 1 | 2018 | 6982 | 0.010 |
Why?
|
Child | 2 | 2021 | 78456 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2896 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12984 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5835 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7271 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7810 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1899 | 0.010 |
Why?
|
Heart Diseases | 1 | 1995 | 2763 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29294 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6146 | 0.010 |
Why?
|
Thrombosis | 1 | 1995 | 2999 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7571 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1995 | 4294 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10300 | 0.010 |
Why?
|
Chlamydia trachomatis | 1 | 1997 | 236 | 0.010 |
Why?
|
Echocardiography | 2 | 1995 | 4909 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15308 | 0.010 |
Why?
|
Chlamydia Infections | 1 | 1997 | 361 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1995 | 11655 | 0.010 |
Why?
|
Heart Ventricles | 2 | 1995 | 3772 | 0.000 |
Why?
|
Mycobacterium tuberculosis | 1 | 1997 | 1860 | 0.000 |
Why?
|
Tuberculosis | 1 | 1997 | 1956 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6320 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1979 | 467 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1979 | 1034 | 0.000 |
Why?
|
Radiography | 1 | 1979 | 6939 | 0.000 |
Why?
|
Coronary Disease | 1 | 1979 | 5924 | 0.000 |
Why?
|